One of the traditional counters to Sweden’s not being all dead yet in the full context of how Europe has done is to claim that Norway did a better job of lockdowns and isolation.
In the age of Omi that has gone out the window. Note that the case peak in Norway is as high or higher than Sweden and Germany while maintaining a lower (though apparently converging) death rate.
The heavy lines are cumulative death rates (Norway remains much lower though now perhaps approaching Sweden and Germany’s slope) while the light lines are peak case rates.
So at least with Omi it’s something about Norway and/or its people/ genetics and not certain that Sweden screwed up. (Admittedly it could mostly also be due to an avoidance of Remdesivir and ventilators if that’s part of what’s going on there among other possibilities.)
Here’s today’s cumulative death chart for a wider swath of Europe plus the US for perspective.
Some things to note:
All these charts are in rates and so are valid comparisons
I have added CDC Fluview seasonality (week 40 - week 39) blue lines so you can see why CDC quietly added a Covid mode to Fluview a while ago. But watch out, as Geert Vanden Bossche now points out in a must watch interview, the disaster the vaccines are creating may even lead to craziness this summer.
GIB is Gibraltar which is one of the most highly vaccinated places on earth — and note that their C19 death spurt occurred during their mass vaccination campaign and caused them to now be relatively in line with the “terrible” US
The country code labels for each line are appended with population median ages where available. Note that some of the relatively low/ positive positioning of Israel (ISR) and Palestine (PSE) can be explained by relatively low median ages … unlike Norway. Pfizer has publicly stated that they consider Israel to be their laboratory of success though the comparatively drastically lower vaccination rate of Palestine (both with young populations) makes that an interesting question
Norway: Definitely not about measures anymore...
Norway: Definitely not about measures anymore...
Norway: Definitely not about measures anymore...
One of the traditional counters to Sweden’s not being all dead yet in the full context of how Europe has done is to claim that Norway did a better job of lockdowns and isolation.
In the age of Omi that has gone out the window. Note that the case peak in Norway is as high or higher than Sweden and Germany while maintaining a lower (though apparently converging) death rate.
The heavy lines are cumulative death rates (Norway remains much lower though now perhaps approaching Sweden and Germany’s slope) while the light lines are peak case rates.
So at least with Omi it’s something about Norway and/or its people/ genetics and not certain that Sweden screwed up. (Admittedly it could mostly also be due to an avoidance of Remdesivir and ventilators if that’s part of what’s going on there among other possibilities.)
Here’s today’s cumulative death chart for a wider swath of Europe plus the US for perspective.
Some things to note:
All these charts are in rates and so are valid comparisons
I have added CDC Fluview seasonality (week 40 - week 39) blue lines so you can see why CDC quietly added a Covid mode to Fluview a while ago. But watch out, as Geert Vanden Bossche now points out in a must watch interview, the disaster the vaccines are creating may even lead to craziness this summer.
GIB is Gibraltar which is one of the most highly vaccinated places on earth — and note that their C19 death spurt occurred during their mass vaccination campaign and caused them to now be relatively in line with the “terrible” US
The country code labels for each line are appended with population median ages where available. Note that some of the relatively low/ positive positioning of Israel (ISR) and Palestine (PSE) can be explained by relatively low median ages … unlike Norway. Pfizer has publicly stated that they consider Israel to be their laboratory of success though the comparatively drastically lower vaccination rate of Palestine (both with young populations) makes that an interesting question